Thirty-three people were taken to the hospital Tuesday morning after authorities responded to calls of people overdosing on K2 near a Brooklyn intersection that has been called one of the worst spots in New York City for synthetic drug use.
Authorities said that it wasn't clear what drug the people who were transported to hospitals had ingested, but the NYPD said that at least five were reportedly smoking the cheap synthetic cannabinoid commonly called K2 outside a building on Stockton Street.
The woman who called 911 to report the men smoking told NBC 4 New York they were vomiting and urinating. Witnesses told DNAinfo that the victims collapsed on the sidewalk and subway platforms.
Since 2015, there have been more than 6,000 K2-related emergency room visits in New York City, according to the city's health department. There have been two confirmed deaths associated with the drug.
Source: 33 Hospitalized After Calls About Mass K2 Overdose in Brooklyn: NYPD | NBC New York http://www.nbcnewyork.com/news/local/K2-Mass-Overdoses-Brooklyn-Bedford-Stuyvesant-NYC-386499841.html#ixzz4EOm5ia00
Follow us: @nbcnewyork on Twitter | NBCNewYork on Facebook
The FDA recently voted in favor of pushing a new formulation of oxycodone hydrochloride for approval. The new OxyContin formula is more difficult to crush or dissolve which will hopefully make it harder to be used as a drug of abuse . The FDA recommended that Purdue Pharma's application for a new, resin-coated formulation should replace the original version, which has been on the market since 1996. Randall Flick, MD, an anesthesiologist at the Mayo Clinic who voted to recommend approval of the drug said, "Clearly the old formulation is worse than the new, although I think the difference is relatively small," Flick concluded, "Hardcore abusers are likely to devise new ways to break down the harder tablet or figure out which solvents will dissolve it fastest, within 'day or weeks' of the product's release on the market."